News Pfizer promotes potential CEO successor Bourla Move could allow CEO Read to focus on mega-merger.
GlaxoSmithKline GSK's new CEO Walmsley paid 25% less than predecessor Witty GlaxoSmithKline (GSK) has confirmed rumours that its incoming CEO Emma Walmsley will be paid less than her predecessor, Sir Andrew Witty.
GlaxoSmithKline GSK under pressure to rein in new CEO pay Emma Walmsley's deal under scrutiny amid crackdown on boardroom pay.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
